Lennox-Gastaut Syndrome: Cannabidiol Treatment
What was the impact of add-on cannabidiol treatment in patients aged 2-55 years experiencing drop seizures?
AAN 2017: Must-See Sessions
You won’t want to miss these new features and sessions at this year’s American Academy of Neurology Annual Meeting, April 22-28, in Boston, MA.
IBIA 2017: Repercussions of TBI
Research presented at IBIA 2017 looked at risk behavior in adolescents, return to work, and maladaptive emotion regulation following TBI.
ACC 2017: Late-Breaking Clinical Trials
Research includes safety of digoxin with atrial fibrillation, comparison of cerebral embolic protection devices, and cerebral microbleed triggers.
ACC 2017: CV Risk Factors
Research includes a possible link between Zika & CV issues, CV effects of cannabis use, and neurocognitive impairment with PCSK9 variants.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
ISC 2017: Vascular Cognitive Impairment
Research included the impact of diet on cognitive decline and the degree of a link between depression & dementia post intracerebral hemorrhage.
Exploratory Trial for Essential Tremor Treatment
In a proof-of-concept study, 25 patients were exposed to a dose-escalating infusion of SAGE-547 to evaluate the drug’s effect on essential tremor.
Modeling Simulations to Predict AED Efficacy
Researchers used simulations to predict the outcomes of epilepsy patients with partial-onset seizures converting to Aptiom monotherapy (800 mg QD).
Potential Treatment for SRSE
Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Antiepileptic Drug Choice: Patient vs Neurologist
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
By clicking Accept, you agree to become a member of the UBM Medica Community.